UK's ImmuPharma rises on "groundbreaking" finding in autoimmune diseases
09/01/2025 08:32
** Shares of ImmuPharma IMM.L jump 17% to 1.41p; stock
among top pct gainers across London
** The drug developer says discovers "groundbreaking"
insights into autoimmune disease mechanisms in pre-clinical
research program
** Says findings pave the way for earlier and more accurate
diagnostics for its autoimmune therapy P140
** Stock fell ~28% in 2024
(Reporting by Aby Jose Koilparambil in Bengaluru)
((abyjose.koilparambil@thomsonreuters.com))